Arteris, Inc. (NASDAQ:AIP – Get Free Report) COO Laurent R. Moll sold 37,561 shares of the business’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $7.49, for a total value of $281,331.89. Following the transaction, the chief operating officer now owns 544,468 shares in the company, valued at approximately $4,078,065.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Arteris Stock Performance
Shares of AIP opened at $7.05 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.14 and a quick ratio of 1.14. Arteris, Inc. has a 12-month low of $4.20 and a 12-month high of $9.54. The business’s fifty day moving average price is $7.86 and its 200 day moving average price is $7.57. The stock has a market capitalization of $271.28 million, a PE ratio of -6.84 and a beta of 1.12.
Arteris (NASDAQ:AIP – Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.07). Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. The business had revenue of $14.58 million during the quarter, compared to the consensus estimate of $13.68 million. During the same quarter in the previous year, the business posted ($0.25) earnings per share. Equities research analysts forecast that Arteris, Inc. will post -0.9 EPS for the current year.
Hedge Funds Weigh In On Arteris
Analyst Ratings Changes
Several equities analysts recently commented on the company. Westpark Capital reissued a “buy” rating and set a $11.00 price target on shares of Arteris in a research report on Wednesday, July 31st. Jefferies Financial Group reissued a “hold” rating and set a $9.00 target price (down from $11.00) on shares of Arteris in a research report on Monday, May 13th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a report on Monday, August 5th.
Check Out Our Latest Analysis on Arteris
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- 3 Warren Buffett Stocks to Buy Now
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- What is a SEC Filing?
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Find and Profitably Trade Stocks at 52-Week Lows
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.